Asieris Pharmaceuticals is a Chinese biotech company. Founded by John Zhuang and Kevin Pan in 2010, Asieris Pharmaceuticals is backed by investors that include Homsun Capital, Haoshuo Zhier Fund, CICC, Qiming Venture Partners, and YF Capital and is headquartered in Shanghai.